Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis
Impact Factor: 4.9 (2023). 5-Year Impact Factor: 5.5 (2023). Se publicó como preprint en: https://www.preprints.org/manuscript/202402.0587/v1
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Other Authors: | |
Format: | info:eu-repo/semantics/publishedVersion biblioteca |
Language: | eng |
Published: |
Academic Editor: Vivek Verma
2024-03-22
|
Subjects: | Inhalable vancomycin, Cystic fibrosis, Polyelectrolyte–drug complex, Hyaluronic acid, Pulmonary infection, |
Online Access: | http://hdl.handle.net/11086/552768 https://www.mdpi.com/1999-4923/16/4/436 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11054002/ http://doi.org/10.3390/pharmaceutics16040436 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|